(19)
(11) EP 2 307 022 A1

(12)

(43) Date of publication:
13.04.2011 Bulletin 2011/15

(21) Application number: 08845326.1

(22) Date of filing: 30.10.2008
(51) International Patent Classification (IPC): 
A61K 31/454(2006.01)
A61K 31/166(2006.01)
A61K 31/196(2006.01)
A61K 47/12(2006.01)
A61K 31/135(2006.01)
A61K 31/192(2006.01)
A61K 47/02(2006.01)
A61P 29/00(2006.01)
(86) International application number:
PCT/CA2008/001919
(87) International publication number:
WO 2009/055925 (07.05.2009 Gazette 2009/19)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 31.10.2007 US 984058 P
29.11.2007 US 991179 P

(71) Applicant: Equitech Corporation
St. Albert, Alberta T8N 1B4 (CA)

(72) Inventors:
  • JAMALI, Fahkreddin
    Edmonton Alberta T6G 2N8 (CA)
  • AGHAZADEH HABASHI, Ali
    Edmonton, Alberta T6K 4E3 (CA)

(74) Representative: Gates, Marie Christina Esther et al
Tomkins & Co. 5 Dartmouth Road
Dublin 6
Dublin 6 (IE)

   


(54) ENHANCED NSAID FORMULATIONS